Promising results regarding the treatment of patients with septic shock with sodium ascorbate – a pH-balanced formulation of vitamin C.
An initial clinical trial at the Austin Hospital in Melbourne is now moving to the next phase and being rolled out across Australia, thanks to a grant of 4.9 million from the Federal Government.
The study found that patients with sepsis who received the sodium ascorbate treatment showed improved kidney function, required less of the clinically used drug -noradrenaline- to restore blood pressure, and showed signs of improved function in multiple organs.
The findings were published in Critical Care on the 13th of October Link to article 'Mega-dose sodium ascorbate: a pilot, single-dose, physiological effect, double-blind, randomized, controlled trial' by Yanase et al. in Critical Care, published the 12th of October 2023
https://ccforum.biomedcentral.com/articles/10.1186/s13054-